InvestorsHub Logo
Followers 1606
Posts 119989
Boards Moderated 3
Alias Born 07/09/2003

Re: None

Wednesday, 03/01/2017 1:28:48 PM

Wednesday, March 01, 2017 1:28:48 PM

Post# of 380011
~TRON .0093 News...

https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=24272


TORON, INC. (OTC:TRON) PROVIDES CORPORATE STATUS REGARDING
CORPORATE ACTIONS AND MERGER WITH IMEDSCAN CORPORATION
MIAMI BEACH, FLORIDA – March 1, 2016 - Toron, Inc (OTC Pink: TRON) provided
its stockholders today with a corporate status regarding corporate actions and merger with
iMedScan corporation.
In August 2016, the interim president Fabrizio Bosticco and others removed the Chief Financial
Officer and Secretary Manuel Soberanes, CPA, in a unilateral action with the Nevada Secretary of
State. Mr. Bosticco then caused 400,000,000 shares of common stock of the company to be issued
to Hudson BA, a Florida corporation for the merger with iMedScan. However, Hudson BA and
Bosticco had no legal interest in iMedScan corporation and paid no consideration to Toron Inc. or
iMedScan for these shares.
On December 29, 2016, Barton Hollow Trust appointed Rene Ortiz Morentin as the Chief
Executive Officer and sole director of Toron, Inc. and removed Mr. Bosticco as the Chief
Executive Officer of Toron Inc. and removed Adam Tracy as Director.
On December 30, 2016, the acquisition agreement with iMedScan was completed. iMedScan will
operate as a wholly-owned subsidiary of Toron. Toron management is currently negotiating
several additional acquisitions.
On February 2, 2017, Toron Inc. requested and the transfer agent retired the shares of Toron Inc.
to Hudson BA. On February 8, 2017, Toron issued 400,000,000 shares of common stock to
Pantheon Partners, who was the lawful owner of iMedScan.
Pantheon Partners, a boutique investment banking firm, has been retained to complete a private
placement for Ten Million Dollars ($10,000,000) to be utilized to fund the operations of iMedScan
and to provide additional funds for pending business acquisitions.
On February 24, 2017, a Special Meeting of Shareholders was held regarding: 1) Adoption of the
Restated Bylaws of the Corporation; and 2) Election of Director, Rene Ortiz Morentin. Both items
were passed. On February 27, 2017, in Clark County District Court 7, the Motion to Discharge
Custodian and Enter Final Order was filed.
iMedScan is a healthcare project development and management company holding a proprietary
technology that provides for the instant verification of a patient’s medical insurance. “iMedScan’s
proprietary technology will generate a twenty-five percent (25%) reduction in patient insurance
rejections or denials from insurance payors,” Morentin said. He continued, “changes in the
healthcare industry have considerably lowered profit margins and increase the costs of healthcare
to consumers; we believe our technology will create significant cost reductions that will benefit
both insurers andinsureds.”
In March 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles,
California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and
insurance cards. Most recently, in June, 2016, iMedScan finalized a test program with Change
America, formerly Emdeon Corporation, utilizing an electronic data interchange for verifying and
validating patients’ health insurance. “We estimate a fifty percent (50%) net profit recapture from
each medical office that adopts our technology,” Morentin noted. Currently, in addition to
traditional medical offices, iMedScan is focusing on the further development and
commercialization of kiosk devices hosting the company’s scanning solution. Based upon the
completion of the acquisition agreement with iMedScan and Toron, the marketing and roll-out
plan of iMedScan will now be implemented.
About Toron, Inc. & iMedScan Corporation
On December 30, 2016, Toron, Inc. entered a definitive Agreement and Plan of Merger with
iMedScan corporation, pursuant to which, upon closing, iMedScan became a wholly-owned
subsidiary of Toron.
iMedScan Corporation is an innovative disruptive healthcare technology company focused on
integrating access to electronic data interfaces (“EDI”) for healthcare providers and payor systems
in a user-friendly manner. iMedScan’s technology provides ease of use for patients by simplifying
their check-in registration process, while at the same time reducing the healthcare providers’
administrative expenses and lost revenues by eliminating insurance rejections, denials or any
incorrect results arising from erroneous or incomplete patient information verification.
iMedScan’s proprietary software technology.
Statements in this press release that are not historical fact may be deemed forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Although Toron, Inc. believes the expectations reflected in any forward-looking statements are
based on reasonable assumptions, Toron, Inc. is unable to give any assurance that its expectations will be attained.
Factors that could cause actual results to differ materially from expectations include the company’s ability to meet the
conditions necessary to, among other matters, obtain a public listing on a major national exchange.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.